Pregabalin for itching in diabetes: a controlled study
Treatments studied
Part of Hormones & metabolism, Pain, Skin clinical trials.
This trial tests if pregabalin can reduce chronic itching in people with type 2 diabetes. It compares pregabalin against a placebo (inactive pill) to see if itching improves more with the active drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and are over 18 years old.
- Your average blood sugar (HbA1c) is less than 10% and your diabetes medicines have been steady for at least 1 month.
- You have had itching for 6 weeks or longer, and it affects at least two body areas (like arms, legs, back, etc.).
- The itching is not caused by a skin condition (like eczema or psoriasis), kidney or liver problems, thyroid issues, or other known causes.
- You have not taken certain medications (like gabapentin, pregabalin, antihistamines, or steroids) for itching or nerve pain in the last 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an extended-release version of pregabalin (a pain medication) for people with long-term nerve pain caused by diabetes or shingles. It aims to see if this once-daily pill can reduce pain with fewer side effects.
This Phase 3 study tests Praga formulation to see if it safely reduces nerve pain caused by diabetes. You may qualify if you’re an adult with painful diabetic neuropathy and have certain symptom and pain scores on questionnaires.
This study tests if a gentle neck stretch (cervical traction) can help people with chronic itch on the scalp, arms, or upper back take less gabapentin or pregabalin (medicines for nerve-related itch). If you have had a stable dose of these medicines for at least four weeks and don't have a skin rash causing the itch, this trial may offer a drug-free way to manage your symptoms.
This trial tests an experimental drug (HSK16149) for people with long-term diabetic nerve pain that hasn't been helped enough by pregabalin. It aims to see if the new capsule can reduce pain more effectively.
This trial tests a new medicine called HRS-2129 for people with long-term nerve pain caused by diabetes. It aims to see if the drug can safely reduce pain.
This trial tests whether adding acupuncture (electroacupuncture) to the standard pain medicine pregabalin can better relieve facial shingles pain that started 1 to 3 months ago. It's for people with moderate pain who are willing to try both treatments together.
Hear when a new Diabetic Pruritus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.